• Sign up to our Free Newsletter
  • Contact Us
Microbiome Times Magazine
  • Human Health
  • Finance
  • Drug Database
    • Login/ Register
    • About
  • Issue Archive
  • Advertise
  • Recruitment Marketing

Pharma & Human Health

Finance

Pragma Bio Secures $10M to Expand Its Proprietary Technology Platform To Discover Novel Medicines

March 24, 2023 Microbiome Times

Pragma Bio, the technology-enabled platform for drug discovery formerly known as VastBiome, announced it has raised an additional $10 million in equity to continue its development of proprietary methods in genomic sequencing, artificial intelligence and […]

Pharma & Human Health

The right cocktail of gut enzymes can stop c. diff in its tracks

March 15, 2023 Microbiome Times

Not all probiotics are created equal. In a new study, researchers found that certain enzymes within a class known as bile salt hydrolases (BSHs) can restrict Clostridioides difficile (C. diff.) colonization by both altering existing bile acids and […]

Pharma & Human Health

Engineered bacteria find tumors, then alert the authorities

March 13, 2023 Microbiome Times

Combining discoveries in cancer immunology with sophisticated genetic engineering, Columbia University researchers have created a sort of  “bacterial suicide squad” that targets tumors, attracting the host’s own immune cells to the cancer to destroy it. […]

Finance

Bacthera Acquires cGMP Manufacturing Site in León (ES) to Strengthen Clinical Supply Capacity

March 13, 2023 Microbiome Times

Basel, Switzerland, and Hørsholm, Denmark, March 13th 2023 – Bacthera, a specialized contract development and manufacturing organization (CDMO), announced today that it has acquired a cGMP manufacturing site in León (ES) from 4D Pharma. Acquiring […]

Pharma & Human Health

Gut bacteria are crucial for liver repair

March 10, 2023 Microbiome Times

When parts of the liver are removed, the body can replace the missing tissue. A team of researchers at the Technical University of Munich (TUM) has now discovered that the success of this process depends […]

Pharma & Human Health

University of Pittsburgh lab shows phage attacks in new light

March 8, 2023 Microbiome Times

As antibacterial resistance continues to render obsolete the use of some antibiotics, some have turned to bacteria-killing viruses to treat acute infections as well as some chronic illnesses. Graham Hatfull, the Eberly Family Professor of […]

Pharma & Human Health

Colorectal cancer surgery: Gut microbiota helps healing

March 8, 2023 Microbiome Times

Published in the journal Gut, the study by scientists at the CHUM Research Centre (CRCHUM) in Montreal identified two bacterial strains that directly affect whether or not anastomotic leakage, more commonly known as intestinal leakage, […]

Finance

Biose Industrie announces the opening of new manufacturing development facility in Boston, MA

March 2, 2023 Microbiome Times

Biose Industrie, a contract development manufacturing organisation (CDMO) and a world-leader of live biotherapeutic product (LBP) process development and production, announced today their plan to open a laboratory in the heart of Boston, Massachusetts, later […]

Finance

Biose Industrie to receive €80M in investment to boost workforce and manufacturing capabilities

February 17, 2023 Microbiome Times

L-GAM and the French State through the “French Tech Souveraineté” scheme have signed a purchase agreement with the aim of acquiring joint control of Biose Industrie, a world leader in the development and production of […]

Pharma & Human Health

Regulatory pathway needs to be developed to make the most of phages

February 16, 2023 Microbiome Times

A regulatory pathway needs to be developed if the UK is to reap the benefits of bacteriophage therapy, Applied Microbiology International (AMI) has warned. France, Belgium and Poland are already developing programmes that take advantage […]

Finance

Prokarium Announces $30 Million Financing to Deliver Lead Program into Clinic and Build Novel Therapeutic Platform

February 10, 2023 Microbiome Times

Prokarium, a biopharmaceutical company leading the oncology field of microbial immunotherapy, has raised $30 million in new funding. This follows Prokarium’s announcement of partnering with Ginkgo Bioworks to leverage its world-class Foundry and extensive Codebase […]

Posts navigation

1 2 … 63 »

Sign Up to Free Newsletter

The Microbiome Drug Database

Editor’s Choice

  • “Probiotics” Green-lit for market-usage by French Authorities
    January 25, 2023
  • Microbiome Drug Development: 2022 in Review
    December 30, 2022
  • Exclusive Interview with Ken Blount, VP Microbiome Research at Ferring Pharmaceuticals
    December 22, 2022
  • FDA Approves First Fecal Microbiota Product
    December 1, 2022
  • Proge Farm claims Europe’s first regulatory approval for a microbiome-based therapeutic
    November 29, 2022
sign up

Sign up to the Microbiome Times newsletter